(Q35560337)

English

Transcriptional Profiling of Laser Capture Microdissected Subpopulations of the Osteoblast Lineage Provides Insight Into the Early Response to Sclerostin Antibody in Rats

scientific article published on 22 May 2015

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

8 August 2017

Transcriptional Profiling of Laser Capture Microdissected Subpopulations of the Osteoblast Lineage Provides Insight Into the Early Response to Sclerostin Antibody in Rats (English)

1 reference

Europe PubMed Central

8 August 2017

0 references

author name string

Paul Nioi

1

1 reference

Europe PubMed Central

8 August 2017

Scott Taylor

2

1 reference

Europe PubMed Central

8 August 2017

Rong Hu

3

1 reference

Europe PubMed Central

8 August 2017

Efrain Pacheco

4

1 reference

Europe PubMed Central

8 August 2017

Yudong D He

5

1 reference

Europe PubMed Central

8 August 2017

Hisham Hamadeh

6

1 reference

Europe PubMed Central

8 August 2017

Chris Paszty

7

1 reference

Europe PubMed Central

8 August 2017

Ian Pyrah

8

1 reference

Europe PubMed Central

8 August 2017

Michael S Ominsky

9

1 reference

Europe PubMed Central

8 August 2017

Rogely Waite Boyce

10

1 reference

Europe PubMed Central

8 August 2017

publication date

22 May 2015

1 reference

Europe PubMed Central

8 August 2017

Journal of Bone and Mineral Research

1 reference

Europe PubMed Central

8 August 2017

30

1 reference

Europe PubMed Central

8 August 2017

8

1 reference

Europe PubMed Central

8 August 2017

1457-1467

1 reference

Europe PubMed Central

8 August 2017

Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Osteocyte control of bone formation via sclerostin, a novel BMP antagonist

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Sclerostin and Dickkopf-1 as therapeutic targets in bone diseases

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Tissue-level mechanisms responsible for the increase in bone formation and bone volume by sclerostin antibody

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Laser capture microdissection technology

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

The Wnt signaling pathway in development and disease

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Deciphering the function of canonical Wnt signals in development and disease: conditional loss- and gain-of-function mutations of beta-catenin in mice

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Identification of differentially expressed genes between osteoblasts and osteocytes

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Demonstration of osteocytic perilacunar/canalicular remodeling in mice during lactation.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

A three-dimensional distribution of osteocyte processes revealed by the combination of confocal laser scanning microscopy and differential interference contrast microscopy

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Dynamics of the transition from osteoblast to osteocyte

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Cdc25B is negatively regulated by p53 through Sp1 and NF-Y transcription factors.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Regulation of embryonic and induced pluripotency by aurora kinase-p53 signaling

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Surveillance mechanism linking Bub1 loss to the p53 pathway

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Constitutive CCND1/CDK2 activity substitutes for p53 loss, or MYC or oncogenic RAS expression in the transformation of human mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

p53 functions as a negative regulator of osteoblastogenesis, osteoblast-dependent osteoclastogenesis, and bone remodeling

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Tight relationships between B lymphocytes and the skeletal system

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Regulation of CXCL12 expression by canonical Wnt signaling in bone marrow stromal cells.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

CXCL12/CXCR4 signal axis plays an important role in mediating bone morphogenetic protein 9-induced osteogenic differentiation of mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Absence of sclerostin adversely affects B-cell survival.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Determination of dual effects of parathyroid hormone on skeletal gene expression in vivo by microarray and network analysis.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Teriparatide (PTH 1-34) treatment increases peripheral hematopoietic stem cells in postmenopausal women

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Sclerostin inhibition reverses skeletal fragility in an Lrp5-deficient mouse model of OPPG syndrome

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Sost downregulation and local Wnt signaling are required for the osteogenic response to mechanical loading.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Osteocytes, mechanosensing and Wnt signaling

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Gene expression patterns in bone following mechanical loading

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Mechanical activation of β-catenin regulates phenotype in adult murine marrow-derived mesenchymal stem cells

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Mechanical induction of Twist in the Drosophila foregut/stomodeal primordium

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Matrix stiffness and serum concentration effects matrix remodelling and ECM regulatory genes of human bone marrow stem cells.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Dlx5, a positive regulator of osteoblastogenesis, is essential for osteoblast-osteoclast coupling.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Differential expression of cxcl-14 during eruptive movement of rat molar germs.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Evaluation of DNA microarray results with quantitative gene expression platforms

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Romosozumab in postmenopausal women with low bone mineral density.

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Sclerostin in Mineralized Matrices and van Buchem Disease

1 reference

https://api.crossref.org/works/10.1002%2FJBMR.2482

21 January 2018

Identifiers

10.1002/JBMR.2482

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

8 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35560337&oldid=1579501134"